Management of Chronic Subdural Hematoma With Adjunctive Embolization of Middle Meningeal Artery: The EMMA-Can Randomized Clinical Trial

EMMA-Can: Canadian multicentre randomised trial of Onyx MMA embolisation within days after surgical drainage, with symptomatic recurrence as primary endpoint.

Highlights

Open at JAMA ↗

Index entry — verify clinical detail against the primary source.

Related conditions

subdural-hematoma

For learning and professional reference; not a patient-specific recommendation. How we prepare content.